| RS2151582276 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151582291 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151582306 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151582311 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151582319 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151582390 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151582400 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151582417 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583226 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583236 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583310 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583407 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583446 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151583480 |
NF1
|
Health Risk |
Likely pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151584780 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151584799 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151584941 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151585015 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151585064 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151585069 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151585074 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151585076 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151585114 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2151585159 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151585265 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151585509 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151585510 |
NF1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Cardiovascular phenotype |
| RS2151585983 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2151586074 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151586233 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151587004 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151587629 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151587645 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151587760 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2151588017 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151588861 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151590002 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151601322 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS2151603267 |
CHD3
|
Health Risk |
Likely pathogenic |
— |
| RS2151603656 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151604078 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151608196 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151609046 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151611619 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151611996 |
TSC2
|
Health Risk |
Likely pathogenic |
— |
| RS2151613782 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151615708 |
CHD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151619821 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151620335 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS2151620921 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151621480 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151622456 |
CHD3
|
Health Risk |
Likely pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151622840 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151625014 |
ZSWIM7
|
Health Risk |
Pathogenic |
Spermatogenic failure 71, Spermatogenic failure 71 |
| RS2151627168 |
CHD3
|
Health Risk |
Likely pathogenic |
— |
| RS2151627285 |
PKHD1
|
Health Risk |
Likely pathogenic |
Autosomal recessive polycystic kidney disease, Autosomal recessive polycystic kidney disease |
| RS2151628196 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151630268 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151631183 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151631825 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Isolated focal cortical dysplasia type II |
| RS2151632008 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151637431 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS2151639120 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151641893 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151641918 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS2151642647 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS2151651792 |
PHKB
|
Health Risk |
Pathogenic/Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2151652750 |
IGF1R
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual disability, Growth delay due to insulin-like growth factor I resistance |
| RS2151657686 |
CHD3
|
Health Risk |
Pathogenic |
— |
| RS2151659413 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151660505 |
ANKRD11
|
Health Risk |
Likely pathogenic |
— |
| RS2151660952 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151660977 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Intellectual disability, Intellectual disability |
| RS2151660984 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2151662496 |
VPS33B
|
Health Risk |
Likely pathogenic |
Arthrogryposis, renal dysfunction |
| RS2151663926 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151663957 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151663964 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151664099 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Abnormal cerebral morphology, Abnormal cerebral morphology |
| RS2151664151 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151665554 |
CHST6
|
Health Risk |
Pathogenic/Likely pathogenic |
Macular corneal dystrophy, Macular corneal dystrophy |
| RS2151666355 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
— |
| RS2151666409 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151666445 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151667298 |
CHD3
|
Health Risk |
Pathogenic |
Snijders Blok-Campeau syndrome, Snijders Blok-Campeau syndrome |
| RS2151667785 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151667800 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151667927 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151667999 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151669999 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151672494 |
PHKB
|
Health Risk |
Likely pathogenic |
Glycogen storage disease IXb, Glycogen storage disease IXb |
| RS2151673809 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151673826 |
PAFAH1B1
|
Health Risk |
Pathogenic |
— |
| RS2151673924 |
PAFAH1B1
|
Health Risk |
Likely pathogenic |
— |
| RS2151673946 |
PAFAH1B1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151674034 |
PAFAH1B1
|
Health Risk |
Pathogenic |
Lissencephaly due to LIS1 mutation, Lissencephaly due to LIS1 mutation |
| RS2151674130 |
IGF1R
|
Health Risk |
Conflicting classifications of pathogenicity |
Growth delay due to insulin-like growth factor I resistance, Growth delay due to insulin-like growth factor I resistance |
| RS2151674791 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 1 |
| RS2151674862 |
VPS33B
|
Health Risk |
Likely pathogenic |
Keratoderma-ichthyosis-deafness syndrome, autosomal recessive |
| RS2151675590 |
ANKRD11
|
Health Risk |
Pathogenic |
KBG syndrome, KBG syndrome |